Tvardi Therapeutics (TVRD) Change in Receivables: 2012-2024
Historic Change in Receivables for Tvardi Therapeutics (TVRD) over the last 11 years, with Dec 2024 value amounting to -$2.4 million.
- Tvardi Therapeutics' Change in Receivables rose 192.86% to $26,000 in Q4 2017 from the same period last year, while for Dec 2017 it was $36,000, marking a year-over-year increase of 414.29%. This contributed to the annual value of -$2.4 million for FY2024, which is 376.36% down from last year.
- As of FY2024, Tvardi Therapeutics' Change in Receivables stood at -$2.4 million, which was down 376.36% from -$495,000 recorded in FY2023.
- Tvardi Therapeutics' Change in Receivables' 5-year high stood at $3.3 million during FY2022, with a 5-year trough of -$2.4 million in FY2024.
- In the last 3 years, Tvardi Therapeutics' Change in Receivables had a median value of -$495,000 in 2023 and averaged $135,667.
- As far as peak fluctuations go, Tvardi Therapeutics' Change in Receivables slumped by 1,020.00% in 2020, and later skyrocketed by 3,296.08% in 2022.
- Yearly analysis of 5 years shows Tvardi Therapeutics' Change in Receivables stood at -$414,000 in 2020, then surged by 75.36% to -$102,000 in 2021, then soared by 3,296.08% to $3.3 million in 2022, then crashed by 115.18% to -$495,000 in 2023, then tumbled by 376.36% to -$2.4 million in 2024.